Kyle Rose
Impact in
- Urology top 10%
- Urological Disorders and Treatments
-
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
Papers in
- Co-authors
- Anojan Navaratnam (8 shared papers)Mark D. Tyson (8 shared papers)Haidar Abdul-Muhsin (7 shared papers)Erik P. Castle (10 shared papers)William G. Eversman (3 shared papers)Roger Li (17 shared papers)Philippe E. Spiess (15 shared papers)Wade J. Sexton (16 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Urologic Oncology Seminars and Original Investigations (5 papers)European Urology Focus (3 papers)Urology (3 papers)The Journal of Urology (2 papers)
- Partner nations
- United StatesItalyAustralia
In The Last Decade
Kyle Rose
36 papers receiving 216 citations
Peers
Comparison fields: 5 of 47
- Urology 50
- Surgery 171
- Pulmonary and Respiratory Medicine 77
- Obstetrics and Gynecology 14
- Cancer Research 24
Countries citing papers authored by Kyle Rose
This map shows the geographic impact of Kyle Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Rose more than expected).
Fields of papers citing papers by Kyle Rose
This network shows the impact of papers produced by Kyle Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Rose. The network helps show where Kyle Rose may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 27 | |
| 2 | 2019 | 23 | |
| 3 | 2019 | 23 | |
| 4 | 2023 | 18 | |
| 5 | 2019 | 15 | |
| 6 | 2021 | 13 | |
| 7 | 2022 | 10 | |
| 8 | 2024 | 8 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 7 | |
| 11 | 2010 | 7 | |
| 12 | 2022 | 5 | |
| 13 | 2019 | 5 | |
| 14 | 2019 | 5 | |
| 15 | Single-dose perioperative mitomycin-C versus thiotepa for low-grade noninvasive bladder cancer. | 2019 | 5 |
| 16 | 2001 | 5 | |
| 17 | 2020 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2023 | 2 |
About Kyle Rose
Kyle Rose is a scholar working on Surgery, Urology, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 42 papers that have together received 217 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (28 papers), Urinary and Genital Oncology Studies (15 papers), Urological Disorders and Treatments (11 papers), Renal cell carcinoma treatment (8 papers), Cancer Genomics and Diagnostics (8 papers), Epigenetics and DNA Methylation (7 papers), Ureteral procedures and complications (4 papers) and Streptococcal Infections and Treatments (2 papers). The work is most often cited by research in Urology (50 citations), Surgery (171 citations), Pulmonary and Respiratory Medicine (77 citations), Obstetrics and Gynecology (14 citations) and Cancer Research (24 citations). Kyle Rose has collaborated with scholars based in United States, Italy and Australia. Frequent co-authors include Anojan Navaratnam, Mark D. Tyson, Haidar Abdul-Muhsin, Erik P. Castle, William G. Eversman, Roger Li, Philippe E. Spiess, Wade J. Sexton, Samuel R. Money and Victor J. Davila. Their work appears in journals such as Journal of Clinical Oncology, Urologic Oncology Seminars and Original Investigations, European Urology Focus, Urology and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.